Agenus Inc.

Grantee Website Lexington, Massachusetts, United States
Purpose
to enable broad access of the potent adjuvant QS-21 to enhance the effectiveness of vaccines targeting infectious and endemic diseases in poor and developing nations
Division
Global Health
Date
NOVEMBER 2018
Region Served
GLOBAL
Committed Amount
$927,365
Grant Topic
Discovery and Translational Sciences,
Malaria
Duration (Months)
38
Grantee Location
Lexington, Massachusetts, United States

More about our work

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.